Top Pharmaceutical Companies (2,036)
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
KMR is a global leader in benchmarking, analytics, and performance management, with an exclusive focus on biopharmaceutical R&D.
Providing patients with comprehensive and compassionate care since 1987, Orsini is the leading, independent specialty pharmacy focused on rare diseases, gene therapies, and complex conditions. Orsini’s high-touch care model centers around compassionate, therapy-specific care teams who provide personalized care to patients based on their specific condition and treatment. The company’s comprehensive solutions include medication adherence programs, data analytics, customized manufacturer...
Peloton Therapeutics is translating groundbreaking scientific insights into first-in-class oral medicines to fight cancer and other serious conditions.
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as...
Daiichi Sankyo's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results indicate sustained year-over-year revenue increases driven primarily by the oncology franchise, notably ENHERTU and DATROWAY. Management maintains forward revenue growth guidance while highlighting continued indication and geographic expansion for these assets.
Strategic Partnerships: Large, multi‑asset collaborations with AstraZeneca and Merck validate the DXd platform and provide capital, development support, and commercial reach. These alliances underpin scale‑up and reinforce the medium‑term growth outlook in oncology.
Strong Market Position & Advantage: The company is recognized as a leader in oncology antibody‑drug conjugates, with ENHERTU establishing leading shares in key indications and additional approvals broadening use. Category leadership is further supported by expanding first‑line and tumor‑agnostic indications.
PHARM-EMPLOI is a leading recruitment agency and training center specializing in the pharmaceutical industry, with a primary focus on community pharmacies (officine). The firm provides expert staffing solutions, predominantly focusing on permanent employment contracts (CDI) to help pharmacies secure top talent. Additionally, PHARM-EMPLOI operates as a specialized training center, offering essential educational resources and professional development for pharmacy professionals.
Seranova Bio is a biotechnology company developing therapeutics from naturally occurring protective autoantibodies. Its REAP platform profiles these antibodies and links their activity to clinical outcomes, helping identify human-supported therapeutic targets and understand disease biology. The company applies this approach to drug discovery across areas including autoimmunity, oncology, and neurodegeneration, with the goal of advancing first-in-class therapies inspired by patient...
Allogenetics is a biotechnology company based in Hannover, Germany, specializing in organ engineering. The company develops first-in-class, immune-evasive technology to create 'Invisible Organs,' aiming to solve the problem of organ rejection after transplantation. By engineering donor organs to be immunologically invisible, Allogenetics seeks to eliminate the need for lifelong immunosuppression and improve patient outcomes in the transplant market.
Regulonix is a biotechnology company that develops non-opioid drugs for chronic pain.
BioDelivery Sciences is a specialty pharmaceutical company focusing on pain management and addiction medicine.
Natural MedTech is manufacturing psychedelic medicines to unlock neurologic potential. We are building Australia’s leading pure-play psychedelic business, with differentiated IP, an experienced team, and a self-funding growth profile.
Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network...
Taaneh is engaged in commercializing the use of diamond particles, an inert material for the authentication, identification and construction of anti-counterfeiting systems. The technology has applications in diverse sectors including the pharmaceutical industry (particularly solid oral dosage forms), prestige cosmetics and fragrances, foods, textiles, inks, currency, mechanical parts and packaging. Taaneh's IP and patent positions are designed to protect the technology that...
Capsule is rebuilding the $425 billion pharmacy industry from the inside out with an emotionally resonant brand and technology that enables customized outcomes for doctors, hospitals, insurers, and manufacturers. Our team makes the same promise to each other as the one we’ve made to our customers, doctors, and partners: everybody needs some looking after sometimes. We’ll never lose sight of...
Maisha Meds has created the first and largest network of private pharmacies and clinics in East Africa through a mobile app that delivers subsidized care. Not only does the app now help over 3,500 businesses operate by making sales, managing inventory, and tracking patients; it also reimburses them for providing affordable care to patients for malaria, birth control, and HIV...
Quantum Health develops and sells science-based herbal health products and dietary supplements for consumers seeking natural alternatives to traditional medicine. Founded in 1981, the company focuses on condition-specific products intended to support everyday health, including cold-sore treatments, lysine supplements, eye-health products, cough drops, and zinc/elderberry remedies. Its mission is to improve quality of life through natural products grounded in scientific...
Quantum Health's Top Stability & Growth Strengths
Market Expansion: Membership and client reach have expanded materially, with the company citing more than 20 million members across over 570 clients after recent acquisitions. Rising demand in employer-sponsored navigation and higher year-over-year member interactions further point to continued expansion.
Strong Revenue Growth: Revenue trajectory is described as rising, including an S&P Global note of 14% growth in 2025 with continued growth expected into 2026. Annual revenue is also estimated in the hundreds of millions, signaling a sizable top line.
Strong Market Position & Advantage: The company is portrayed as a pioneer and benchmark brand in employer healthcare navigation, supported by proprietary Real-Time Intercept technology and repeated industry recognition. Scale spanning millions of members and hundreds of enterprise clients reinforces a durable competitive footing.
For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies,...
Merck's Top Stability & Growth Strengths
Strong Market Position & Advantage: Merck holds a clear leadership position, anchored by Keytruda—the world’s top‑selling cancer medicine at $31.7B in 2025—and strong standings in vaccines and overall scale among global pharmas. Animal health also ranks among top players, reinforcing breadth across key healthcare markets.
Innovation-Driven Growth: A broad late‑stage pipeline and scientific presence (100+ ASCO 2026 abstracts across 25+ tumor types) span oncology, vaccines, infectious disease, and cardiometabolic areas. Ongoing label expansions and new formats like subcutaneous Keytruda (including U.S. Keytruda Qlex) are adding growth vectors.
Diversified Revenue Streams: Sales draw from oncology, vaccines (e.g., Gardasil over $10.7B in 2025), hospital acute care, and a growing animal health segment. Newer launches and alliances (e.g., Winrevair, IDVYNSO, and partnered oncology assets) are contributing to mix.
Serum Institute of India Pvt. Ltd. is now the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least...
PolyNovo is a disruptive ASX 200 medical technology company. Its products simplify managing acute complex wounds, redefining healing with differentiated outcomes across many etiologies. After treating 62,000+ patients across 46 countries, the company is investing for growth via new products, indications and markets with a view to treat millions more. Our registered address is 2/320 Lorimer St, Port Melbourne, Victoria...
